Clinical Trial

Study on Lipid Profile Changes in Plasma and Intestinal Mucosa of Patients With Inflammatory Bowel Disease

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 12, 2024 (before its estimated February 25, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aimed to demonstrate the characteristic lipid profile changes in patients with inflammatory bowel disease.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-11-06; most recent amendment 2024-12-10.
Trial Details
NCT Number NCT06680076
Lead Sponsor First Affiliated Hospital of Harbin Medical University
Conditions Inflammatory Bowel Diseases
Enrollment 90 participants
Start Date 2024-12
Primary Completion 2025-02-25 (estimated)
Study Completion 2025-03-30 (estimated)
Updated on ClinicalTrials.gov 2024-12-12